Wanjia Group Reports Widened Annual Loss, Shareholder Deficit Expands by 49%
Stock News
Jun 29
WANJIA GROUP (ASX: 00401) has disclosed its financial results for the fiscal year ended March 31, 2026.
The company recorded revenue of HK$165 million, representing a 2.28% increase compared to the previous year.
However, the loss attributable to the company's owners widened to HK$9.864 million, marking a significant 49.09% year-on-year increase.
This resulted in a loss per share of 1.38 HK cents.
The company stated that the revenue growth was primarily driven by increased business demand for its pharmaceutical products from clients such as hospitals and medical institutions in China's Fujian Province.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.